Skip to main content

Table 2 Comparisons of the ELBW infants whose DA closed with 1st course of COI vs. who did not close with 1st course

From: Failure of a repeat course of cyclooxygenase inhibitor to close a PDA is a risk factor for developing chronic lung disease in ELBW infants

 

Closed (n = 26)

Not Closed (n = 54)

P

BW, gm

764 (23)

749 (17)

ns

GA, wks

25.6 (0.2)

25.0 (0.1)

0.014

Male Gender (%)

14 (54%)

24 (44%)

ns

CRIB II score

12.0 (0.4)

12.6 (0.3)

ns

OI

3.4 (0.3)

4.5 (0.3)

ns

Age 1st Dose, days

5.5 (0.8)

6.8 (1.4)

ns

Fluid 1st 3 days, ml/k/d

114 (5)

113 (2)

ns

UOP before Rx, ml/k/h

3.7 (0.2)

3.9 (0.2)

ns

UOP during Rx, ml/k/h

3.3 (0.3)

3.2 (0.2)

ns

UOP after Rx, ml/k/h

3.3 (0.3)

3.2 (0.2)

ns